logo

Actinium Pharmaceuticals Inc (ATNM)



Trade ATNM now with
  Date
  Headline
11/23/2020 7:05:38 AM Actinium Highlights Foundational Patents Covering Composition Of Apamistamab And Iomab-B And Recent EU Patent Activity
11/19/2020 7:31:17 AM Actinium Appoints Avinash Desai EVP Of Clinical Development, Operations And Medical Affairs
10/28/2020 7:09:42 AM Actinium Pharma Sees Multiple Milestones In Q4 From ARC Pipeline Incl Phase 3 Data From Pivotal SIERRA Trial
10/21/2020 7:15:00 AM Actinium Pharma Awarded Grant To Study Novel Iomab-ACT Targeted Conditioning With A CD19 CAR T-Cell Therapy
10/14/2020 7:02:26 AM Actinium Pharma Unveils Launch Of Its New R&D Lab Facility In New York City
10/6/2020 7:03:58 AM Actinium Pharma Announces Clinical Trial Site Expansion In Multi-Center Phase 1/2 Actimab-A Venetoclax Combination Trial
9/23/2020 7:02:06 AM Actinium Pharma Completes First Dosing Cohort In Phase 1 Study Of Actimab-A And Venetoclax Combination Therapy
9/14/2020 7:03:01 AM Actinium Pharma Provides Update On Actimab-A CLAG-M Combination Phase 1 Trial
8/10/2020 2:47:16 PM Actinium Pharma Announces Reverse 1-for-30 Stock Split
6/19/2020 5:25:28 PM Actinium Pharmaceuticals, Inc. Announces Closing Of $25.0 Million Public Offering
6/16/2020 11:35:06 PM Actinium Pharma Announces Pricing Of Public Offering Of 76.92 Mln Shares At $0.325/Shr
6/16/2020 4:04:25 PM Actinium Pharma Announces Proposed Public Offering
4/21/2020 11:37:51 PM Actinium Pharma Announces Public Offering Of 183.33 Mln Shares At $0.15/Shr